I-Mab
Utility Patents
Last updated:
List of all I-Mab patents 12 in total
Status | Patent |
---|---|
Grant | Utility: Anti-PD-L1 antibody and IL-7 fusions Filling date: 6 Sep 2025 Issue date: 2 Aug 2022 |
Grant | Utility: Anti-claudin 18.2 and anti-4-1BB bispecific antibodies and uses thereof Filling date: 6 Sep 2025 Issue date: 1 Mar 2022 |
Grant | Utility: Anti-PD-L1 antibodies and uses thereof Filling date: 6 Sep 2025 Issue date: 11 Jan 2022 |
Grant | Utility: Human PD-L1 antibodies Filling date: 6 Sep 2025 Issue date: 28 Dec 2021 |
Grant | Utility: Anti-IFNAR1 antibodies for treating autoimmune diseases Filling date: 6 Sep 2025 Issue date: 13 Jul 2021 |
Grant | Utility: Anti-CD73 anti-PD-L1 bispecific antibodies Filling date: 6 Sep 2025 Issue date: 15 Jun 2021 |
Grant | Utility: Anti-CXCL13 antibodies Filling date: 6 Sep 2025 Issue date: 8 Jun 2021 |
Grant | Utility: Antibodies to T cell immunoreceptor with IG and ITIM domains (TIGIT) and uses thereof Filling date: 6 Sep 2025 Issue date: 13 Apr 2021 |
Grant | Utility: Anti-GM-CSF antibodies and uses thereof Filling date: 6 Sep 2025 Issue date: 12 Jan 2021 |
Grant | Utility: Anti-PD-L1 antibodies and uses thereof Filling date: 6 Sep 2025 Issue date: 28 Jul 2020 |
Grant | Utility: Anti-CD73 antibodies and uses thereof Filling date: 6 Sep 2025 Issue date: 10 Mar 2020 |
Grant | Utility: Anti-LAG-3 antibodies and uses thereof Filling date: 6 Sep 2025 Issue date: 3 Mar 2020 |
Showing 1 to 12 of 12 patents.